11-5200202-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004760.3(OR51V1):āc.481C>Gā(p.Pro161Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000955 in 1,612,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004760.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR51V1 | NM_001004760.3 | c.481C>G | p.Pro161Ala | missense_variant | 1/1 | ENST00000641270.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR51V1 | ENST00000641270.1 | c.481C>G | p.Pro161Ala | missense_variant | 1/1 | NM_001004760.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000556 AC: 84AN: 151192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000164 AC: 41AN: 249936Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135416
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461278Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 726990
GnomAD4 genome AF: 0.000555 AC: 84AN: 151310Hom.: 0 Cov.: 32 AF XY: 0.000581 AC XY: 43AN XY: 73964
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.499C>G (p.P167A) alteration is located in exon 1 (coding exon 1) of the OR51V1 gene. This alteration results from a C to G substitution at nucleotide position 499, causing the proline (P) at amino acid position 167 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at